ABSTRACT
Although C-type RNA viruses have been associated with lymphocytic neoplasms in a wide variety of mammalian and avian species, little is known of the cellular mechanism by which they induce lymphomas. Even the question of whether these viruses transform their target cells directly or induce lymphomas by indirect means has not been settled. This is largely due to certain experimental drawbacks of the murine viruses generally used in such studies, for example, Gross passage A and Moloney leukemia viruses. First, there is generally a latent period of many months between time of infection and appearance of the tumor (generally a thymic lymphoma), a duration which obscures the oncogenic events (1) . Second, there has been no system for transformation of lymphoid cells in vitro. An in vitro system would require a rapidly acting virus, the appropriate class of lymphocyte targets, a method for stimulating cellular DNA synthesis (required for viral replication and transformation) (2), conditions for keeping the lymphocytes alive in culture long enough to be transformed, and a means of determining whether the infected cells were oncogenically transformed. Transforma Transplantation System. Injection of mice with pristane before tumor cell inoculation greatly enhances transplantation of plasmacytomas (8) and Abelson lymphomas without affecting the rapidity or total incidence of lymphoma induction by Abelson virus (Sklar, Shevach, Green, and Potter, manuscript in preparation). Therefore, all recipient mice were injected intraperitoneally with 0.5 ml of pristane 1-6 weeks before injection of spleen lymphocyte cultures or tumor cells.
Karyotyping. Tumor-bearing mice were injected with colchicine, 1 Ag/g of body weight. After 1.5 hr, cells were obtained from ascites and were karyotyped by standard methods, using Giemsa staining or quinacrine mustard banding (9, 10).
Experimental Design. A sample (0.05 ml) of the Abelson virus pool was added to each of the cultures to be infected, either at the time of planting (day 0) or after 24 or 48 hr.
At 4-7 days after planting (3-6 days after infection), floating and adherent cells (removed by scraping) were washed by centrifugation and injected intraperitoneally into recipient mice, either BALB/c or CALF1. Viable cells (3 to 6 X 106; by trypan blue exclusion) were injected into each mouse. In the experiments with CALF1 recipients, the control mice received a mixture of uninfected control cultures of cells derived from mice treated with pristane for both intervals (20 or 30 days) (total of 6 X 106 cells per mouse). To control for the possibility of tumors induced by graft-versus-host reactions (known to occur when parental splenocytes are injected into F1 hybrids with a parent with a different H-2 marker), six pristane-treated CALF1 mice were each injected with 5 X 107 normal BALB/c splenocytes each week for 3 weeks.
Mice were examined every 2 days for the presence of ascites or adenopathy. Tumors that arose were classified by gross and microscopic pathology, and were tested for myeloma protein secretion into the ascites by agar electrophoresis. The heavy chain classes of the immunoglobulin produced by the plasmacytoma were typed by double-diffusion in agar (Ouchterlony).
In the initial experiments, the origin of the tumors was determined by infecting female (XX) spleen cells in vitro, injecting these cells into male (XY) mice, and scoring karyotypes of the resulting tumors for the presence or absence of the Y chromosome. Although male cells into female hosts would have been technically easier to karyotype, we hoped to avoid possible difficulties due to transplantation antigens on the male cells.
However, using the X and Y chromosomes as markers (as in Fig. 1) . Karyotyping: Female Cells into Male Mice (Group A). Attempts were made to karyotype ascites tumor cells from transplants of each of the four tumors in group A2. Adequate preparations were obtained only for the plasmacytoma, no. A2-1. A total of 25 metaphases were screened; the chromosome number ranges were 37-42 and 80-85. Nine quinacrine-stained cells were karyotyped in order to determine their sex. Table  2A shows that three were female (see Fig. 1A and C) and five were male (Fig. 1B) . The sex of one cell could not be determined due to missing chromosomes.
It is not known whether the male cells in the tumors represent contamination with normal host cells or new tumor induction in the host by the virus produced by the transplanted cells. Whatever the source of the male metaphases, the female cells can only have originated in vitro.
Translocation Marker. In groups B3-B5, the tumors arising in the initial CALF1 recipients of infected spleen cells were transplanted again in CALF1 mice. Screening of metaphases from the ascites tumors that developed (Table 2B) showed that all of the cells in tumors B3-1 and B5-1 were without a translocation and had 40 chromosomes (normal BALB/c karyotype). Ascites tumors arising in two separate recipients of tumor B4-1 were analyzed. B4-la yielded 98/100 cells with 40 chromosomes and without the translocation, while B4-lb yielded 50/50 cells with 39 chromosomes and with the translocation (normal CALF1 karyotype).
These results clearly show that tumors B3-1, B5-1, and B4-la were of BALB/c origin; thus, they derive from cells infected in vitro. The other 2/100 cells of recipient karyotype in B4-la might represent either host cell contamination or tumor induced de novo by the virus produced by the injected tumor cells. The latter is probably the case with the 50/50 CALF1 karyotypes in B4-lb.
Since we had found CALF1 mice to be quite sensitive to the Abelson virus (unpublished), we feared the possibility of a high background of virus-induced host tumor cells in the above experimental group. In an attempt to circumvent this possibility, we also transplanted some tumors (B6-1 to B6-4) from CALF1 to CBF1 mice. As previously mentioned, this strain should act as a filter, selectively permitting transplantation of cells descended from those infected in vitro while rejecting those from the CALFM host (because of H-2 incompatabilities). Because CBF1 is also relatively virus resistant, the problem of new tumor induction by cell-borne virus should be minimized.
We have never observed an Abelson virus-induced tumor in less than 20 days in mice of any age or strain, and 26 days is the shortest latent period observed for an adult mouse Proc. Nat. Acad. Sci. USA 71 (1974) developing lymphoma. While cells producing virus can prob-DISCUSSION ably deliver a higher effective titer of the virus than injection
These results indicate that we have obtained lymphomas of a cell-free virus preparation, the latent periods for tumor from cells infected in vitro with a murine lymphoma virus. development are essentially identical in mice injected with
In the case of the plasmacytoma, two different immunovirus alone and in mice (not pristane-treated) injected with globulins were produced and both male and female karyovirus-producing cells (which do not transplant readily in such types were present. Without cloning, it is impossible to mice) (ref. 4 ; Sklar, Shevach, Green, and Potter, manuscript ascertain which immunoglobulin was synthesized by which in preparation).
cell. However, the presence of cells both with and without Although the CBF1 mice are considerably more resistant Y chromosomes suggests that the plasma cell tumor has a to these "background" tumors, we only included in this mixed origin, i.e., that some cells originated from in vitro report tumors that transplanted into CBF1 mice in less than transformation and others from de novo tumorigenesis in the 20 days. Recipients of tumors B6-1, B6-2, B6-3, and B64, host. which developed tumors at 16,10,19, and 11 days, respectively, While it is clear that the tumors contained cells from the after injection of primary tumor ascites cells, showed transcultures infected in vitro, we do not yet know that the location-free karyotypes (Table 2B) . Because of the short oncogenic events occurred before injection into mice. Since latent period, these tumors must represent growth of transtransformed lymphocytes are not necessarily distinguishable planted cells, and consequently must have originated in vitro.
histologically from normalor mitogen-stimulated lymphocytes, One of the principal potential values of this system is that it provides a means of studying the mechanism by which a C-type RNA lymphoma virus can oncogenically transform lymphocytes, the cell type with which C-type virus expression and tumorigenesis are most often associated. However, it should be noted that transformation of lymphocytes by the Abelson virus in vitro does not bear on the question of whether the thymic lymphoma viruses directly transform their target lymphocytes.
Since there is evidence that the Abelson virus transforms B-lymphocytes in vivo, the in vitro system described here should provide a means of studying viral transformation of a well-defined cell population with more available functional and genetic markers than any other cell type. Cell separation procedures are available to select homogeneous lymphoid subpopulations for transformation. For example, cells with receptors for a given antigen could be separated from lymphoid tissue from mice immunized to that antigen by using the cell separator of Herzenberg and coworkers (13, 14) . DNA synthesis could then be stimulated by lipopolysaccharide or other mitogens, or by the specific antigen, followed by transformation with Abelson virus. In the absence of the cell separator, specific antigen could be used to stimulate the desired subpopulation of B-lymphocytes. Resulting tumors would be tested both for specific receptor and production of specific antibody. The effect of virus transformation on B lymphoid surface antigens, antibody production, B-cell maturation, and other B-cell functions could all be studied independently of host antiviral and antitumor mechanisms.
Virus transformation of such antigen-specific cells may give rise to lymphomnas and plasmacytomas with known antibodybinding activity.
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Note Added in Proof. It has recently come to our attention that Lieberman and Kaplan [(1966) Nat. Cancer Inst. Monograph 22, 549-554] presented evidence that initiation of thymocyte transformation may have occurred following exposure to radialion leukemia virus in vitro.
